Physician profile
Ali Haider
NPI 1962665265
$491,962.22
in general payments reported to CMS, 2019-2025
54 companies · $51K in 2025
The $51K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $88K · 2020: $74K · 2021: $115K · 2022: $95K · 2023: $25K · 2024: $45K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $28K · Consulting Fee: $27K · Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Long Term Medical Supply Or Device Loan: $429 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,229.00 |
| Travel and Lodging | $27,513.78 |
| Consulting Fee | $27,050.00 |
| Food and Beverage | $19,164.22 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,550.00 |
| Long Term Medical Supply Or Device Loan | $429.00 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $260,049.22 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $66,368.59 | 2019-2023 | Farxiga |
| Amgen INC. | $42,654.87 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $38,651.75 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $30,932.50 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Azure Xt Dr Mri Surescan |
| Glaxosmithkline, LLC. | $16,231.94 | 2024-2025 | Shingrix |
| Edwards Lifesciences Corporation | $9,780.09 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Eko Health, INC. | $6,689.00 | 2020-2023 | |
| Boston Scientific Corporation | $3,537.69 | 2019-2025 | Avvigo Guidance System, General - Tachy, Comet |
| Abbott Laboratories | $3,514.37 | 2019-2025 | Navitor, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Butterfly Network, INC. | $2,028.00 | 2020 | |
| Inari Medical, INC. | $1,644.26 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $1,025.38 | 2019-2020 | |
| Irras USA, INC. | $956.50 | 2019 | |
| Abiomed | $938.94 | 2022-2025 | Impella |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $923.76 | 2019-2025 | |
| Stryker Corporation | $741.77 | 2019-2025 | Flowtriever |
| Cardiovascular Systems INC. | $613.86 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $457.22 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $401.72 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $374.73 | 2019-2025 | Camzyos |
| Philips North America LLC | $352.40 | 2019-2025 | Multi Modality Ivus Other Systems, Image Guided Therapy Agito |
| Opsens INC. | $350.96 | 2022 | |
| Biotronik INC. | $309.55 | 2019-2022 | |
| Amarin Pharma, INC. | $198.75 | 2019-2022 | |
| Pfizer INC. | $171.54 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $170.69 | 2019-2025 | Dupixent |
| Endologix LLC | $160.40 | 2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Ekos Corporation | $150.96 | 2019 | |
| Novo Nordisk INC | $146.13 | 2024-2025 | Ozempic |
| Merck Sharp & Dohme LLC | $145.68 | 2021-2022 | |
| Penumbra, INC. | $138.05 | 2024 | Indigo System |
| Impulse Dynamics (USA) INC. | $120.70 | 2023 | Optimizer |
| Esperion Therapeutics, INC. | $118.04 | 2020-2022 | |
| Zoll Circulation INC | $112.75 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Alnylam Pharmaceuticals INC. | $103.82 | 2019-2023 | Onpattro |
| Intact Vascular, INC. | $80.00 | 2019 | |
| Angiodynamics, INC. | $75.76 | 2021 | |
| Cardiva Medical, INC. | $75.41 | 2025 | Cardiva Vascade 5f Vcs |
| Kestra Medical Technology Services, INC. | $62.88 | 2024-2025 | Assure Wcd |
| Heartflow, INC. | $61.57 | 2024-2025 | |
| Chiesi USA, INC. | $45.58 | 2025 | Cleviprex, Kengreal |
| Becton, Dickinson and Company | $42.30 | 2025 | Progel Applicator Spray Tips |
| Kiniksa Pharmaceuticals, Ltd. | $36.75 | 2021-2022 | |
| Terumo Medical Corporation | $35.59 | 2019-2020 | |
| Acist Medical Systems, INC. | $25.78 | 2022 | |
| Getinge USA Sales, LLC | $23.10 | 2022 | |
| Janssen Scientific Affairs, LLC | $22.91 | 2022 | |
| Bridgebio Pharma, INC. | $21.43 | 2025 | Attruby |
| Amryt Pharma Holdings Ltd | $20.25 | 2021 | |
| Venclose INC. | $18.47 | 2020 | |
| Siemens Medical Solutions USA, INC. | $18.18 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.55 | 2019 | |
| Bardy Diagnostics, INC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,781.25 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Haider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.